Suraksha Diagnostic Limited (SURAKSHA) — Announcement | 17 August 2026

17 August 2026 · NSE Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Suraksha Diagnostic reports Q1 FY'27 growth and outlines expansion plans

🔄 What Changed

Revenue and PAT growth accelerated to 21% and 40% YoY, EBITDA margin improved to 36%, and center count increased to 72 with new hubs in Jharkhand and Tripura

🔮 What's Next

Targeting 33-34% EBITDA margin by FY'28-'29 and expanding to 100 centers by FY'28 with Rs 70-80 crores capex

💡 Investor Takeaway

Shareholders should note accelerating growth and margin expansion supported by scalable genomics and center network growth

Suraksha Diagnostic reported strong Q1 FY'27 results with 21% revenue growth, 28% EBITDA growth, and 40% PAT growth, driven by expansion to 72 centers including new hubs in Jharkhand and Tripura, and 136% genomics revenue growth. Management targets 33-34% EBITDA margin by FY'28-'29 and plans Rs 70-80 crores capex to reach 100 centers by FY'28, while highlighting sustainable margins and B2C dominance in genomics.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SURAKSHA ✨ Ask AI About This

About Suraksha Diagnostic Limited (SURAKSHA)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹1,809.55 CrP/E: 50.5ROE: 14.6%ROCE: 16.6%Div Yield: 0.14%

View full SURAKSHA stock details →

📡 Get AI alerts when SURAKSHA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SURAKSHA — Free

💡 Ask AI about this filing

"How will EBITDA margin expansion be sustained with new center openings?""What is the expected revenue contribution from new hubs in Jharkhand and Tripura?""When will the 100-center target be achieved and what capex milestones are planned?"

Ask AI Free →

📊 More SURAKSHA filings

Announcement — 28 September 2026Suraksha Diagnostic Limited announced that its trading window will close on 1 October 2026 and remai...
🟡 Voting Results — 24 September 2026Suraksha Diagnostic Limited held its 21st AGM on September 22, 2026 via video conference, approving ...
🟡 Board Meeting — 23 September 2026Suraksha Diagnostic held its 21st AGM on September 22, 2026, approving audited standalone and consol...
🟡 Board Meeting — 22 September 2026Suraksha Diagnostic held its 21st AGM on September 22, 2026, approving audited standalone and consol...
🟡 Board Meeting — 27 August 2026Suraksha Diagnostic announced its 21st Annual General Meeting will be held on 22 September 2026 via ...

See all SURAKSHA filings →

🔥 Also filed on 17 August 2026

PREMIERENEPremier Energies LimitedAnnouncement ABCAPITALAditya Birla Capital LimitedCorporate Action VIVIMEDLABVivimed Labs LimitedAnnouncement GSPCROPGSP Crop Science LimitedFinancial Results SEDEMACSEDEMAC Mechatronics LimitedAnnual Report AFFLEAffle 3i LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SURAKSHA files new disclosures

Track SURAKSHA filings, board meetings, and corporate actions. Free email alerts at 5 PM.